Clinical Trials Directory

Trials / Completed

CompletedNCT01942551

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Dongkook Pharmaceutical Co., Ltd. · Industry
Sex
Male
Age
20 Years – 29 Years
Healthy volunteers
Accepted

Summary

This is an open-label, two-arm, one-sequence, cross-over study to evaluate the safety and pharmacokinetic interaction after oral concomitant administration of tadalafil and dutasteride in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGTadalafil
DRUGDutasteride

Timeline

Start date
2013-09-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2013-09-16
Last updated
2015-01-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01942551. Inclusion in this directory is not an endorsement.

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride (NCT01942551) · Clinical Trials Directory